Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
25. August 2022 07:30 ET
|
Todos Medical Ltd.
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune Long COVID Panel and Provista research-use-only MonkeyPox assays to assess effect of TPoxx...
Todos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR Testing
22. August 2022 06:30 ET
|
Todos Medical Ltd.
Provista begins validation preparations for blood-based IgM/IgG MonkeyPox LDTCompany to release its Q2/2022 10Q quarterly report at 4:05 pm ET this afternoonCompany to host business update conference...